83 related articles for article (PubMed ID: 25997728)
1. Current radiosynthesis strategies for 5-HT2A receptor PET tracers.
Herth MM; Knudsen GM
J Labelled Comp Radiopharm; 2015 Jun; 58(7):265-73. PubMed ID: 25997728
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
[TBL] [Abstract][Full Text] [Related]
3. Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging.
T L'Estrade E; Hansen HD; Erlandsson M; Ohlsson TG; Knudsen GM; Herth MM
ACS Chem Neurosci; 2018 Jun; 9(6):1226-1229. PubMed ID: 29763291
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.
Herth MM; Kramer V; Piel M; Palner M; Riss PJ; Knudsen GM; Rösch F
Bioorg Med Chem; 2009 Apr; 17(8):2989-3002. PubMed ID: 19329329
[TBL] [Abstract][Full Text] [Related]
5. 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.
Debus F; Herth MM; Piel M; Buchholz HG; Bausbacher N; Kramer V; Lüddens H; Rösch F
Nucl Med Biol; 2010 May; 37(4):487-95. PubMed ID: 20447561
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the serotonin 2A receptor selective PET tracer (R)-[
Kramer V; Dyssegaard A; Flores J; Soza-Ried C; Rösch F; Knudsen GM; Amaral H; Herth MM
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):355-365. PubMed ID: 31606832
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT
Edgar FG; Hansen HD; Leth-Petersen S; Ettrup A; Kristensen JL; Knudsen GM; Herth MM
J Labelled Comp Radiopharm; 2017 Oct; 60(12):586-591. PubMed ID: 28856700
[TBL] [Abstract][Full Text] [Related]
9. Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.
Yang KC; Stepanov V; Martinsson S; Ettrup A; Takano A; Knudsen GM; Halldin C; Farde L; Finnema SJ
Int J Neuropsychopharmacol; 2017 Sep; 20(9):683-691. PubMed ID: 28911007
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L
J Nucl Med; 1998 Jan; 39(1):208-14. PubMed ID: 9443763
[TBL] [Abstract][Full Text] [Related]
11. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.
Stenbaek DS; Kristiansen S; Burmester D; Madsen MK; Frokjaer VG; Knudsen GM; Fisher PM
Hum Brain Mapp; 2019 May; 40(7):2117-2124. PubMed ID: 30633430
[TBL] [Abstract][Full Text] [Related]
12. Convergent
Petersen IN; Villadsen J; Hansen HD; Jensen AA; Lehel S; Gillings N; Herth MM; Knudsen GM; Kristensen JL
Bioorg Med Chem; 2016 Nov; 24(21):5353-5356. PubMed ID: 27624522
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A
Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
Kumar JS; Prabhakaran J; Erlandsson K; Majo VJ; Simpson NR; Pratap M; Van Heertum RL; Mann JJ; Parsey RV
Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis and evaluation of [18F]MHMZ.
Herth MM; Debus F; Piel M; Palner M; Knudsen GM; Lüddens H; Rösch F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1515-9. PubMed ID: 18187324
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
[TBL] [Abstract][Full Text] [Related]
18. Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar rats.
Visser AK; Meerlo P; Ettrup A; Knudsen GM; Bosker FJ; den Boer JA; Dierckx RA; van Waarde A
Synapse; 2014 Sep; 68(9):379-86. PubMed ID: 24823545
[TBL] [Abstract][Full Text] [Related]
19. A practical synthesis of the serotonin 5-HT2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [11C]labeled PET ligands.
Ullrich T; Rice KC
Bioorg Med Chem; 2000 Oct; 8(10):2427-32. PubMed ID: 11058037
[TBL] [Abstract][Full Text] [Related]
20. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.
Ettrup A; Holm S; Hansen M; Wasim M; Santini MA; Palner M; Madsen J; Svarer C; Kristensen JL; Knudsen GM
Mol Imaging Biol; 2013 Aug; 15(4):376-83. PubMed ID: 23306971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
